$96.1 Million is the total value of Polaris Venture Management Co IV LLC's 4 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLRN | Sell | Acceleron Pharma Inc | $59,715,000 | -34.5% | 1,887,319 | -21.2% | 62.12% | -18.3% |
| PULM | New | Pulmatrix Inc | $15,282,000 | – | 1,591,862 | +100.0% | 15.90% | – |
| ALIM | Alimera Sciences Inc | $14,514,000 | -8.0% | 3,148,355 | 0.0% | 15.10% | +14.8% | |
| CERU | Cerulean Pharma Inc | $6,612,000 | -48.9% | 1,437,441 | 0.0% | 6.88% | -36.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Acceleron Pharma Inc | 12 | Q3 2016 | 85.9% |
| Alimera Sciences Inc | 12 | Q3 2016 | 16.4% |
| Cerulean Pharma Inc | 10 | Q3 2016 | 10.8% |
| Pulmatrix Inc | 6 | Q3 2016 | 15.9% |
| TechTarget Inc | 2 | Q1 2014 | 8.1% |
View Polaris Venture Management Co IV LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2020-05-06 |
| 3 | 2020-04-30 |
| 4 | 2018-04-05 |
| 13F-HR | 2017-02-14 |
| 13F-HR | 2017-02-14 |
| 13F-HR | 2016-05-13 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-10 |
| 13F-HR | 2015-08-11 |
| 4/A | 2015-06-25 |
View Polaris Venture Management Co IV LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.